Kevin Young
2010
In 2010, Kevin Young earned a total compensation of $4.2M as Executive Vice President, Commercial Operations at Gilead Sciences, a 8% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $630,219 |
|---|---|
| Option Awards | $1,319,181 |
| Salary | $664,175 |
| Stock Awards | $1,573,250 |
| Other | $5,000 |
| Total | $4,191,825 |
Young received $1.6M in stock awards, accounting for 38% of the total pay in 2010.
Young also received $630.2K in non-equity incentive plan, $1.3M in option awards, $664.2K in salary and $5K in other compensation.
Rankings
In 2010, Kevin Young's compensation ranked 1,306th out of 10,439 executives tracked by ExecPay. In other words, Young earned more than 87.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,306 out of 10,439 | 88th |
Division Manufacturing | 468 out of 3,837 | 88th |
Major group Chemicals And Allied Products | 101 out of 925 | 89th |
Industry group Drugs | 57 out of 684 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 7 out of 147 | 95th |
Source: SEC filing on March 19, 2013.
Young's colleagues
We found five more compensation records of executives who worked with Kevin Young at Gilead Sciences in 2010.
2010
John Martin
Gilead Sciences
Chief Executive Officer
2010
John Milligan
Gilead Sciences
Chief Operating Officer
2010
Gregg Alton
Gilead Sciences
Executive Vice President, Corporate and Medical Affairs
2010
Norbert Bischofberger
Gilead Sciences
Chief Scientific Officer
2010
Robin Washington
Gilead Sciences